Pfizer, Inc. News

Do you have an interest in the products developed by Pfizer, Inc., or are you interested in the performance of the company? If you are you should register for the free Pfizer, Inc. news email from Wiser. Pfizer, Inc. is an American-based pharmaceutical company that researches, develops and manufactures medicines and vaccines. The products developed by the company are used all over the world. They include leading brands like Lipitor, Zithromax and Viagra. The company was founded in 1849 and today is one of the largest pharmaceutical companies in the world. Its current chairman and CEO is Ian Reed. Most analysts expect Pfizer, Inc. to expand through acquisitions over the coming years. The Wiser daily Pfizer, Inc. news email covers this news as well as analysis on the performance of the company, and details about its products. These articles come from the best sources around the web and are delivered in a comprehensive but simple to use format. Sign up today.

Recent Pfizer, Inc. News Coverage
 
Your Weekly Recommendations Wednesday, November 22, 2017
 
Recommended for you
Trump White House Logs Document Drug Industry Visitors, Meetings
ThinkAdvisor • Caroline Chen
First two-drug HIV treatment regimen gets US FDA approval
Daily Mail • Dailymail.Com, Natalie Rahhal
UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK
Reuters • Reuters Staff
A new drug to treat HIV just got approved — and it could shake up a $22 billion market
Business Insider • Lydia Ramsey
What Is Blockchain Technology?
CB Insights • Arieh Levi
AT&T-Time Warner suit highlights Uncle Sam's merger clout — here are some of his greatest hits
The Business Journals • Jeff Jeffrey
US FDA approves first two-drug HIV regimen
Channel NewsAsia World News
U.S. FDA approves first two-drug HIV regimen
Reuters • Reuters Staff
Texas Instruments: The Next Dividend Aristocrat
Seeking Alpha • Paul Anderson
ViiV Healthcare says FDA has approved its two-drug HIV regimen, in first such instance
MarketWatch • Emmacourt, Reporter
 
Recommended for You
Copyright, Corporate Governance
Trump White House Logs Document Drug Industry Visitors, Meetings
ThinkAdvisorCaroline Chen
Drug company executives were among the many visitors to the White House complex this year, according to visitor logs published Tuesday by ProPublica after a nonprofit transparency group, Property of the People, successfully sued the Trump administration to release the records. From...
Share
GlaxoSmithKline plc, Infectious Disease
First two-drug HIV treatment regimen gets US FDA approval
Daily MailDailymail.Com, Natalie Rahhal
For the first time, a two-drug HIV treatment regimen was been given the US FDA's seal of approval on Tuesday. The therapy, called Juluca, is one of a growing number of treatment options designed to reduce the number of drugs - and...
Share
GlaxoSmithKline plc, Pfizer, Inc.
UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK
ReutersReuters Staff
NEW YORK () - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. The...
Share
GlaxoSmithKline plc, Pfizer, Inc.
A new drug to treat HIV just got approved — and it could shake up a $22 billion market
Business InsiderLydia Ramsey
The FDA just approved a new combination of drugs to treat HIV. The treatment uses two drugs instead of three or more, which has been the standard. The new approval could shake up the $22 billion HIV drug market. The FDA approved...
Share
Bitcoin, Pfizer, Inc.
What Is Blockchain Technology?
CB InsightsArieh Levi
Few people understand what it is, but Wall Street banks, IT organizations, and consultants are buzzing about blockchain technology. It's hard to remove blockchain from Bitcoin, so we'll start with the cryptocurrency as we work to understand this technology's potential. Bitcoin. Blockchain....
Share
Barack Obama, Economic Policy
AT&T-Time Warner suit highlights Uncle Sam's merger clout — here are some of his greatest hits
The Business JournalsJeff Jeffrey
Craig Warga The Trump administration’s lawsuit to block AT&T's acquisition of Time Warner has sent shock waves throughout Wall Street and the nation's mergers-and-acquisition sector, despite years of aggressive antitrust enforcement by former President Barack Obama. According to industry experts, it's been...
Share
GlaxoSmithKline plc, Pfizer, Inc.
US FDA approves first two-drug HIV regimen
Channel NewsAsia World News
NEW YORK: The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at easing the side effects for long-term patients who are on the standard treatment involving three or more...
Share
GlaxoSmithKline plc, Health Care Industry
U.S. FDA approves first two-drug HIV regimen
ReutersReuters Staff
NEW YORK () - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. The...
Share
Finance, Investment Industry
Texas Instruments: The Next Dividend Aristocrat
Seeking AlphaPaul Anderson
Summary Texas Instruments has raised its dividend by an average of 28% over the past 2 years. TXN has increased its dividend for 14 consecutive years. Wall Street has really taken to liking TXN’s dedication to shareholders. Dividend Growth Investors (DGIs) focus...
Share
Finance, GlaxoSmithKline plc
ViiV Healthcare says FDA has approved its two-drug HIV regimen, in first such instance
MarketWatchEmmacourt, Reporter
ViiV Healthcare, which is majority-owned by GlaxoSmithKline and has Pfizer Inc. and Shionogi as shareholders, said on Tuesday that the Food and Drug Administration has approved its two-drug HIV regimen. The therapy, Juluca, is the first such HIV drug composed of just...
Share